Q3 FY2026 · ended Sep 30, 2026 · Revenue $501.37M, +1.7% YoY · Filed Oct 29, 2026
Pediatrix Medical Group, Inc. (MD) files with the SEC under industry code 8060, Services-Hospitals. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $501.4 million and net income of $47.0 million. As of Sep 30, 2026 it held $425.8 million in cash and investments and $432.1 million in total debt.
Revenue
$501.37M
+1.7% vs year-ago quarter
Net income
$46.99M
-34.5% vs year-ago quarter
Operating cash flow
$117.31M
-14.6% vs year-ago quarter
Free cash flow
—
EPS
$0.59
-29.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
78.12M
-9.0% vs year-ago quarter
Net cash
$-6.22M
Q3 FY2026
Operating margin
10.9%
TTM
Company profile
- Industry
- Services-Hospitals (SIC 8060)
- Listed as
- MD (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Sunrise, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 893949
- Former names
- MEDNAX, INC. (until Jun 21, 2022); PEDIATRIX MEDICAL GROUP INC (until Jan 2, 2009)
Other Services-Hospitals companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $501.4M | $487.8M | $476.2M | $493.8M | $492.9M |
| Operating income | $65.2M | $56.9M | $41.7M | $48.8M | $68.1M |
| Net income | $47.0M | $39.8M | $29.6M | $33.7M | $71.7M |
| Diluted EPS | $0.59 | $0.49 | $0.36 | $0.40 | $0.84 |
| Operating cash flow | $117.3M | $125.3M | -$129.8M | $114.1M | $137.3M |
| Total assets | $2.1B | $2.1B | $2.1B | $2.2B | $2.2B |
| Total liabilities | $1.3B | $1.2B | $1.2B | $1.4B | $1.3B |
| Stockholders' equity | $849.6M | $881.0M | $878.6M | $865.9M | $890.7M |
| Cash and investments | $425.8M | $404.2M | $329.0M | $499.7M | $463.1M |
| Total debt | $432.1M | $433.8M | $437.3M | $637.5M | $616.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 24, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 15, 2026 | Jul 15, 2026 |
All 1002 Pediatrix Medical Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.